Novartis Accelerates Alcon Spinoff

GALWAY, IRELAND--November 28, 2018--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Swiss pharmaceutical major Novartis International AG (NYSE:NVS) (Basel, Switzerland) is pushing ahead with its planned spinoff of its Alcon eye-care business in the first half of next year.

Within this article: Details proposed Alcon spin-off, estimated value, current sales and product streams, related Novartis restructuring